Business Context and Reporting Period
NUR Macroprinters Ltd. (Nasdaq-SCM: NURM), a supplier of wide-format inkjet production printing systems, filed a Form 6-K on February 26, 2004, reporting results for the fourth quarter and full year ended December 31, 2003. The company announced a return to profitability on a non-GAAP basis and positive operating cash flow following a comprehensive restructuring plan, including a new management team, relocation of U.S. headquarters to the New York metropolitan area, and consolidation of manufacturing in Israel.
Key Financial Metrics
Fourth Quarter 2003 (vs. Q4 2002)
- Revenue: $18.2 million (down from $19.5 million).
- GAAP Net Loss: $4.8 million ($0.28 per share), driven by $5.3 million in extraordinary charges and inventory write-offs.
- Non-GAAP Net Income: $0.5 million ($0.03 per share), excluding restructuring and inventory charges.
- Operating Cash Flow: Positive for the quarter.
- Liquidity: Cash and cash equivalents totaled $10.9 million at period end, bolstered by a $2.0 million exercise of convertible stand-by loans.
Full Year 2003 (vs. Full Year 2002)
- Revenue: $65.6 million (down from $85.3 million).
- GAAP Net Loss: $27.7 million ($1.60 per share), including $24.1 million in extraordinary charges and write-offs.
- Non-GAAP Net Loss: $3.6 million ($0.21 per share), a significant improvement from the prior year's non-GAAP loss of $6.0 million.
- Debt: Short-term bank credit and loans increased to $15.1 million from $5.8 million; long-term loans remained stable at approximately $30.0 million.
Material Changes
The most significant change is the shift from GAAP losses to non-GAAP profitability in Q4 2003, attributed to the completion of a restructuring plan. While GAAP results reflect a $5.3 million charge for inventory write-offs and lease improvements, management asserts these are one-time items related to the reorganization. Revenue declined year-over-year due to market conditions and the restructuring process, but the company reports stabilized operations and improved manufacturing capacity. The company also renegotiated loan covenants with its banks to better align with its new business plan.
Guidance, Outlook, and Risks
Management Commentary and Outlook
Management expects the trend of improving operating profit (non-GAAP) to continue. The company plans to introduce new products at trade shows in Q2 2004 (Sign UK, ISA, and DRUPA).
2004 Guidance
- Q1 2004 Revenue: $17.0 million to $18.0 million.
- Q1 2004 Gross Margin: 40% to 41%.
- Q1 2004 Operating Expenses: $7.0 million to $8.0 million.
- Q1 2004 Net Income: Nominal profit or zero cents per share.
- Full Year 2004 Revenue: $80.0 million to $82.0 million.
- Full Year 2004 Operating Expenses: $29.0 million to $32.0 million.
- Full Year 2004 Net Profit: $2.0 million to $2.5 million ($0.08 to $0.12 per share).
Risks and Contingencies
Forward-looking statements are subject to risks including changes in economic conditions, decline in product demand, inability to develop new technologies, and competitive pressure on prices. The filing notes that the company's accumulated deficit remains significant at $53.1 million.
Investor Verification Checklist
- Non-GAAP Adjustments: Verify the specific composition of the $5.3 million Q4 and $24.1 million full-year 2003 charges excluded from non-GAAP results to assess the sustainability of the reported profitability.
- Cash Flow Sustainability: Confirm that positive operating cash flow can be maintained without further reliance on convertible loan exercises or equity raises.
- Debt Covenants: Review the specific terms of the renegotiated bank loan covenants to ensure compliance with the new financial targets.
- Revenue Recovery: Monitor Q1 2004 revenue against the $17-18 million guidance to validate the turnaround trajectory.
- Inventory Levels: Assess the remaining inventory balance ($15.9 million) against the write-offs to ensure no further significant impairments are necessary.